Back to search

Article

A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.

2025-12-24

Abstract excerpt

<title>Abstract</title> <p>Background Clinicians need scalable, statistically rigorous maps of disease–disease co-occurrence to support screening, safer prescribing, and differential diagnosis. Spontaneous-report data such as FAERS are national in scope but prone to bias, so discovery requires conservative, interpretable validation. Methods We developed a three-stage pipeline—Association Rule Mining for candida...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b9aa89a-c0ff-5fd8-a44a-f69169421886
DOI
10.21203/rs.3.rs-8311672/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Hybrid Pharmacovigilance Method for National-Scale Comorbidity Discovery: Association Rules with FDA-Approved PRR/Chi-square and EBGM Validation.DOI 10.21203/rs.3.rs-8311672/v1
Select a neighboring publication to make it the new centre.